Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

5.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.1K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

65
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
65
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

273
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
273

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Slr protein of Streptococcus pyogenes is selectively expressed in vivo and is a target for protective antibodies.

EMBO molecular medicine·2026
Same author

Identification of immunostimulatory antigens in Group A <i><i>Streptococcus</i></i>-derived vesicles.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Highly transformable Haemophilus influenzae as a potential amplifier of quinolone resistance dissemination.

The Journal of antimicrobial chemotherapy·2026
Same author

Making hand hygiene visible: a simple laboratory exercise using soil to demonstrate spore-forming bacteria control.

Journal of microbiology & biology education·2026
Same author

MAIT cell responses to <i>S. aureus</i> and sensitivity to HlgAB are modulated by activation and tissue-dependent virulence effects.

bioRxiv : the preprint server for biology·2026
Same author

Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic Patterns.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Oct 21, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.0K

Adjunctive Rifampicin Increases Antibiotic Efficacy in Group A Streptococcal Tissue Infection Models.

H Bergsten1, L M Palma Medina1, M Morgan2

  • 1Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

Antimicrobial Agents and Chemotherapy
|September 7, 2021
PubMed
Summary
This summary is machine-generated.

Adding rifampin to standard antibiotics significantly improves bacterial clearance in necrotizing soft tissue infections (NSTI). This study shows rifampin enhances antibiotic effectiveness against Streptococcus pyogenes biofilms.

Keywords:
Streptococcus pyogenesbiofilmnecrotizing soft tissue infectionsrifampicin

More Related Videos

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.1K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.8K

Related Experiment Videos

Last Updated: Oct 21, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.0K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.1K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.8K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Necrotizing soft tissue infections (NSTI) caused by Streptococcus pyogenes (group A Streptococcus [GAS]) are complicated by bacterial biofilms.
  • Biofilms contribute to persistent GAS infections despite antibiotic treatment.

Observation:

  • This study evaluated benzylpenicillin and clindamycin, with or without rifampin, in a human organotypic skin model and in vitro cellular monolayers.
  • GAS strains were isolated from NSTI patients and infected tissues for 24 or 48 hours.

Findings:

  • Adjunctive rifampin significantly enhanced bacterial clearance in the skin model (97.5% vs. 93.9%, P=.006).
  • Microcalorimetry revealed rifampin decreased metabolic activity and extended the lag phase in GAS strains (P<.05).
  • A case report demonstrated successful adjunctive rifampin treatment for persistent GAS NSTI.

Implications:

  • Adjunctive rifampin shows promise for improving treatment outcomes in GAS-related NSTI.
  • Rifampin may be a valuable addition to standard antibiotic therapy for biofilm-associated infections.
  • Further clinical studies are warranted to confirm these findings in patients.